Alexander Rosenstein Net Worth

The estimated Net Worth of Alexander Rosenstein is at least $3.53 Million dollars as of 24 August 2020. Mr. Rosenstein owns over 4,692 units of Cardiovascular Systems stock worth over $1,682,900 and over the last 8 years he sold CSII stock worth over $817,284. In addition, he makes $1,028,370 as General Counsel and Corporate Secretary at Cardiovascular Systems.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

or

Sign up with Google Sign up with Facebook

Mr. Rosenstein CSII stock SEC Form 4 insiders trading

Alexander has made over 12 trades of the Cardiovascular Systems stock since 2016, according to the Form 4 filled with the SEC. Most recently he sold 4,692 units of CSII stock worth $149,862 on 24 August 2020.

The largest trade he's ever made was selling 6,308 units of Cardiovascular Systems stock on 28 August 2019 worth over $318,049. On average, Alexander trades about 637 units every 46 days since 2016. As of 24 August 2020 he still owns at least 84,145 units of Cardiovascular Systems stock.

You can see the complete history of Mr. Rosenstein stock trades at the bottom of the page.

Alexander Rosenstein biography

Alexander Rosenstein serves as General Counsel and Corporate Secretary of the Company. Mr. Rosenstein joined us in September 2014 as Corporate Legal and Compliance Counsel, became Corporate Secretary in November 2014, and was promoted to General Counsel in March 2015. From October 2005 to September 2014, Mr. Rosenstein was an attorney at Fredrikson & Byron, P.A., which provides legal services to us from time to time, and from September 1998 to September 2005, he was an attorney practicing in New York City.

What is the salary of Alexander Rosenstein?

As the General Counsel and Corporate Secretary of Cardiovascular Systems, the total compensation of Alexander Rosenstein at Cardiovascular Systems is $1,028,370. There are 5 executives at Cardiovascular Systems getting paid more, with Scott Ward having the highest compensation of $4,718,960.

How old is Alexander Rosenstein?

Alexander Rosenstein is 48, he's been the General Counsel and Corporate Secretary of Cardiovascular Systems since 2015. There are 17 older and 7 younger executives at Cardiovascular Systems. The oldest executive at Cardiovascular Systems Inc. is Augustine Lawlor, 64, who is the Independent Director.

What's Alexander Rosenstein's mailing address?

Alexander's mailing address filed with the SEC is 1225 OLD HIGHWAY 8 NW, , ST. PAUL, MN, 55112.

Insiders trading at Cardiovascular Systems

Over the last 16 years, insiders at Cardiovascular Systems have traded over $72,999,461 worth of Cardiovascular Systems stock and bought 949,532 units worth $8,687,068 . The most active insiders traders include Capital Management Lp Camber, Augustine Lawlor, and Capital Ltdmaverick Capital.... On average, Cardiovascular Systems executives and independent directors trade stock every 14 days with the average trade being worth of $338,920. The most recent stock trade was executed by Martha Goldberg Aronson on 15 August 2022, trading 2,411 units of CSII stock currently worth $48,220.

What does Cardiovascular Systems do?

Cardiovascular Systems, Inc., based in St. Paul, Minn., is a medical device company focused on developing and commercializing innovative solutions for treating vascular and coronary disease. The company's orbital atherectomy system treats calcified and fibrotic plaque in arterial vessels throughout the leg and heart and addresses many of the limitations associated with existing surgical, catheter and pharmacological treatment alternatives.

Complete history of Mr. Rosenstein stock trades at Cardiovascular Systems

Cardiovascular Systems executives and stock owners

Cardiovascular Systems executives and other stock owners filed with the SEC include:

• Scott Ward,
  Chairman of the Board, President, Chief Executive Officer
• Rhonda Robb,
  Chief Operating Officer
• Scott Raymond Ward B.Sc., M.S., MS,
  Chairman, Pres & CEO
• Scott Raymond Ward M.S., MS, B.Sc.,
  Chairman, Pres & CEO
• Jeffrey Points,
  Chief Financial Officer
• Alexander Rosenstein,
  General Counsel and Corporate Secretary
• Ryan Egeland,
  Chief Medical Officer
• Rhonda J. Robb,
  Chief Operating Officer
• Sandra Sedo,
  Chief Compliance Officer
• Jeffrey S. Points,
  Chief Financial Officer
• Alexander Rosenstein,
  Gen. Counsel & Corp. Sec.
• Dr. Ryan D. Egeland M.D., Ph.D.,
  Chief Medical Officer
• Edward Brown,
  Independent Director
• Augustine Lawlor,
  Independent Director
• Martha Aronson,
  Independent Director
• Erik Paulsen,
  Independent Director
• William Cohn,
  Independent Director
• Stephen Stenbeck,
  Independent Director
• Stephen Rempe,
  Chief Human Resource Officer
• Kelvin Womack,
  Independent Director
• David Whitescarver,
  Vice President - Corporate Development and Intellectual Property
• John Hastings,
  Vice President - Manufacturing and Operations
• Stephen J. Rempe,
  Chief HR Officer
• David S. Whitescarver,
  VP of Corp. Devel. & Intellectual Property
• Sandra M. Sedo,
  Chief Compliance Officer
• John M. Hastings,
  Exec. VP of Operations & Technology
• John E. Nielsen,
  VP of Investor Relations & Corp. Communications
• Brent G Blackey,
  Director
• Leslie Trigg,
  Director
• Capital Management Lp Camber,
  10% owner
• Scott A Bartos,
  Director
• Laurence L Betterley,
  Chief Financial Officer
• Kevin J. Kenny,
  Chief Operating Officer
• Laura Gillund,
  Chief Talent Officer
• Sachin H. Jain,
  Director
• Capital Ltdmaverick Capital...,
  
• Gary M Petrucci,
  Director
• Paul A. Koehn,
  SVP Quality & Operations
• James E Flaherty,
  Chief Administrative Officer
• Glen D Nelson,
  Director
• Robert J Thatcher,
  Executive VP
• David Martin,
  President and CEO
• Geoffrey O Hartzler,
  Director
• Brian Doughty,
  VP of Marketing
• Paul A Tyska,
  VP of Business Dev
• Roger J Howe,
  Director
• Group I, Llc Donoghue Danie...,
  
• John H Friedman,
  Director
• Scott William Kraus,
  VP Sales
• Advisors, Inc Bonderman Dav...,
  
• Geoffrey M Duyk,